These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5270204)

  • 1. The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus.
    Downie JC; Stuart-Harris CH
    J Hyg (Lond); 1970 Jun; 68(2):233-44. PubMed ID: 5270204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines.
    Downie JC
    J Hyg (Lond); 1973 Sep; 71(3):433-45. PubMed ID: 4518342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to influenza in ferrets. VII. Effect of previous infection with heterotypic and heterologous influenza viruses on the response of ferrets to inactivated influenza virus vaccines.
    McLaren C; Potter CW
    J Hyg (Lond); 1974 Feb; 72(1):91-100. PubMed ID: 4522247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of common colds in human volunteers by influenza C virus.
    Joosting AC; Head B; Bynoe ML; Tyrrell DA
    Br Med J; 1968 Oct; 4(5624):153-4. PubMed ID: 5681050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to influenza in ferrets. V. Immunization with inactivated virus in adjuvant 65.
    Potter CW; McLaren C; Shore SL
    J Hyg (Lond); 1973 Mar; 71(1):97-106. PubMed ID: 4511952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccine.
    Ruben FL; Potter CW; Stuart-Harris CH
    Arch Virol; 1975; 47(2):157-66. PubMed ID: 1119940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase- and hemagglutinin-inhibiting antibodies in serum and nasal secretions of volunteers immunized with attenuated and inactivated influenza B-Eng-13-65 virus vaccines.
    Downie JC
    J Immunol; 1970 Sep; 105(3):620-6. PubMed ID: 5311581
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine.
    Potter CW; Jennings R; McLaren C; Clarke A
    Arch Virol; 1975; 48(4):307-16. PubMed ID: 1200844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to vaccination with a live influenza virus (H3N2) vaccine ("Ann" strain).
    Prévost JM; Peetermans J; Lamy F; Huygelen C
    Infect Immun; 1973 Sep; 8(3):420-4. PubMed ID: 4729931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines.
    Slepushkin AN; Schild GC; Beare AS; Chinn S; Tyrrell DA
    J Hyg (Lond); 1971 Dec; 69(4):571-8. PubMed ID: 5002644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Freestone DS; Hamilton-Smith S; Schild GC; Buckland R; Chinn S; Tyrrell DA
    J Hyg (Lond); 1972 Sep; 70(3):531-43. PubMed ID: 4506997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of neutralizing, haemagglutination-inhibiting and strain-specific complement-fixing antibodies in guinea pigs given inactivated influenza vaccine.
    Závadová H; Vonka V
    Acta Virol; 1968 Mar; 12(2):151-6. PubMed ID: 4384403
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine.
    Bergmann KC; Waldman RH; Tischner H; Pohl WD
    Int Arch Allergy Appl Immunol; 1986; 80(1):107-9. PubMed ID: 3957442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines.
    Shvartsman YS; Agranovskaya EN; Zykov MP
    J Infect Dis; 1977 May; 135(5):697-705. PubMed ID: 858947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proteins in nasal secretion. II. A longitudinal study of IgA and neutralizing antibody levels in nasal washings from men infected with influenza virus.
    Rossen RD; Butler WT; Waldman RH; Alford RH; Hornick RB; Togo Y; Kasel JA
    JAMA; 1970 Feb; 211(7):1157-61. PubMed ID: 5466966
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of "Alice" influenza virus vaccine in normal healthy adults.
    Zaky DA; Douglas RG; Betts RF; Roth FK; Rinehart CJ; Hogan PW
    J Infect Dis; 1976 Jun; 133(6):669-75. PubMed ID: 946973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.